Healthcare -
Biotechnology - NASDAQ - US
$ 15.85
5.46 %
$ 482 M
Market Cap
-2.62
P/E
Price Target
Average
213.88%
Revenue Forecast
Estimate
67.04%
EBIT
Estimate
25.91%
Net Income
Estimate
2.17%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
AnaptysBio, Inc.
Wall Street analysts predict an average 1-year price target for ANAB of $49.8 , with forecasts ranging from
a
low of
$19 to a high of $90 .
ANAB Lowest Price Target
Wall Street Target
19 USD
19.87%
ANAB Average Price Target
Wall Street Target
49.8 USD
213.88%
ANAB Highest Price Target
Wall Street Target
90 USD
467.82%
REVENUE FORECAST
Revenue Forecast Chart ANAB
EBIT FORECAST
EBIT Forecast Chart ANAB
NET INCOME FORECAST
Net Income Chart ANAB